17.03.2022 12:51:42

Alnylam Files Patent Infringement Suits Against Pfizer And Moderna On COVID-19 Vaccines

(RTTNews) - Alnylam Pharmaceuticals Inc. (ALNY) said Thursday that it has separately filed suit in United States District Court for the District of Delaware against Pfizer Inc. and Moderna, Inc., seeking damages for infringement of U.S. Patent No. 11,246,933 in the parties' manufacture and sale of their mRNA COVID-19 vaccines.

The patent relates to Alnylam's biodegradable cationic lipids that are foundational to the success of the mRNA COVID-19 vaccines.

Alnylam said it does not plan to seek an injunction or take action that impedes production, sale or distribution of the vaccines.

Analysen zu Moderna Incmehr Analysen

19.11.24 Moderna Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
13.09.24 Moderna Underweight JP Morgan Chase & Co.
05.08.24 Moderna Sector Perform RBC Capital Markets
12.01.24 Moderna Outperform RBC Capital Markets
03.11.23 Moderna Buy Goldman Sachs Group Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Alnylam Pharmaceuticals Inc. 262,30 0,15% Alnylam Pharmaceuticals Inc.
Moderna Inc 39,29 -0,91% Moderna Inc
Pfizer Inc. 24,77 -2,02% Pfizer Inc.